For example, it has been demonstrated that fxr knockout mice had insulin resistance and hyperglycemia; meanwhile, FXR agonist GW4064 administration decreased serum glucose, increased liver glycogen, and improved insulin sensitivity. This evidence concerns the gene NR1H4 and Insulin resistance.